AAMC Objects
to OMB's Proposed "Daughter of Shelby" Directive
The AAMC has strong concerns for a notice [66
FR 34489] of proposed guidelines published by the Office of Management
and Budget (OMB) on June 28 that would purportedly arbitrate the "quality,
objectivity, utility, and integrity" of all information disseminated
by federal agencies (including the NIH and the National Science Foundation).
The heart of the notice requires federal agencies to develop administrative
mechanisms for "affected persons" to "seek and obtain correction" of
information, as required by a provision in the FY 2001 Treasury/Postal
Appropriations Act (PL 106-554).
At a meeting of the National Academies
on March 13, James Tozzi of the Center
for Regulatory Effectiveness described the legislated provision
as the "daughter of Shelby," in reference to 1998 legislation requiring
public access to research data under the Freedom of Information Act.
Industry proponents have advocated for both provisions (data access
and data quality) as a means to contest research findings that may form
a basis for public health, environmental, or other regulation.
Of particular concern to AAMC are the proposed OMB guidelines in defining
quality, utility, objectivity, and integrity of governmental information
set forth the following criterion: "[W]ith respect to scientific research,
the results must be substantially reproducible upon independent analysis
of the underlying data." This criterion, though an idealized characterization
of scientific communication, would be inoperative as a constructive
guideline to federal oversight of research and the use of scientific
information. It also unnecessarily reprises many contentious and highly
problematic issues - such as the definition of "data" - addressed in
the OMB's final rule on the Shelby provision.
The AAMC is currently preparing a response to the OMB's proposed guidelines.
The Association believes that peer review plays, and should continue
to play, the decisive role in the validation and dissemination of scientific
or other research, whether that research includes federal involvement
or not. The proposal for federal agencies or external interests to serve
as a censor for peer reviewed scientific communication is unwarranted
and profoundly objectionable.
Public comments are due to OMB by Aug. 13 and should be addressed to
Brooke Dickson, Office of Information and Regulatory Affairs, OMB, Washington,
DC 20503. OMB intends to finalize the comments before Sept. 30; federal
agencies will have one year to develop and implement procedures in compliance
with the final guidelines.
Information: Steve Heinig, AAMC
Division of Biomedical and Health Sciences Research, 202-828-0488.